IBS Treatment Market Analysis Report 2023 In-depth Insights by Top Manufacturers 2028

Newest Research on “IBS Treatment Market” – Forecast by Top Regions 2023-2028

Irritable bowel syndrome (IBS) is a common disorder that affects the digestive system. IBS is characterized by symptoms such as stomach cramps, bloating, diarrhea, and constipation, which impacts one’s everyday life. Although the cause of IBS is unknown, but few factors that cause IBS are severe infection, inflammation in the intestines, muscle contractions in the intestine, changes in bacteria in the gut, and abnormalities in the nerves.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for IBS Treatment estimated at USD million in the year 2022, is projected to reach a revised size of USD million by 2028, growing at a CAGR of Percent during the forecast period 2022-2028.
Rising prevalence of gastrointestinal diseases and disorder, geriatric population, unhealthy diet, anxiety, depression, and changing lifestyle in Americas are the key drivers of the Americas IBS market. Moreover, strong clinical pipeline and government support is fuelling the market in this region. According to an updated report by the Anxiety and Depression Association of America, in 2017, the most common mental disorder was anxiety in the United States, affecting approximately 40 million adults over 18 years every year.

Major Product Types of IBS Treatment covered are: